Do You Have Dry Macular Degeneration?

4.4 out of 5 Stars (2,000+ Reviews)

Your Vision.
Your Choice.

Find Out if Valeda Right Therapy is Right for You!

<br />

Valeda Light Therapy — A Breakthrough in Dry Macular Degeneration Treatment

FDA-approved light therapy designed to stimulate your retina and help improve vision. Now available at Kovach Eye Institute in Illinois.

If you’ve been told there’s nothing you can do about dry AMD, there’s new hope. Valeda Light Therapy is an FDA-approved treatment that works differently than other options. Instead of just slowing progression, it’s designed to stimulate your retinal cells and help improve your vision. Quick sessions. Minimal side effects. Real results.

Dry AMD Doesn’t Have to Mean Giving Up

A dry macular degeneration diagnosis can feel like a dead end. You’ve probably heard: ‘There’s no treatment. Just monitor it. Take your vitamins.’ And you watch your central vision slowly fade, making reading harder, driving riskier, independence more uncertain.

But dry AMD isn’t a one-way street anymore.

For decades, patients with dry AMD had limited options. Wet AMD could be treated with injections. But dry AMD? Doctors could only recommend supplements and lifestyle changes. That left millions of people feeling helpless…Until now.

What is Valeda Light Therapy?

A non-invasive treatment backed by clinical research and FDA approval. Valeda Light Therapy uses a specific wavelength of light to stimulate the cells in your retina. Here’s the science:

Your retina has cells called photoreceptors. In dry AMD, these cells gradually break down, causing vision loss. Valeda’s light therapy is designed to energize these cells at the mitochondrial level, essentially giving them the boost they need to function better.

The result? Your retina may work more efficiently, potentially improving your vision and reducing drusen (the protein deposits that accumulate in dry AMD).

What makes it different:

Not an injection (no needles)
Not a medication (no systemic side effects)
Not just ‘slowing progression’—designed to help improve vision
FDA-approved (November 2024)
Backed by clinical trials

What Patients Say:

I have macular degeneration and have been receiving injections from Dr. Saad at Kovach Eye Institute for some time. While I’m essentially blind in my right eye, I was considered a good candidate for Valeda® Light Therapy on my left eye. After completing the first round of nine treatments, I’ve noticed things appear clearer, sharper, and more defined. The treatment itself was quick—only about five minutes—and completely painless. I would absolutely recommend exploring this treatment option at Kovach Eye Institute.- Dave S.

The Treatment Process

What to Expect: Simple, Quick Sessions
Valeda Light Therapy is straightforward:

Session Details:

Duration: Approximately 20 minutes per session
Location: Kovach Eye Institute (in-office)
Comfort: You sit comfortably while the device delivers light therapy to your eye
Side Effects: Minimal; most patients tolerate it very well
Both Eyes: Can be treated in the same session

Treatment Schedule:

Initial course: Typically 9 sessions over 4–6 weeks
Maintenance: Many patients benefit from additional rounds (2–3 per year)
Your doctor will recommend the best schedule for your specific condition

Get Started Today!

Backed by Science. Proven Safe.

Valeda Light Therapy isn’t experimental—it’s evidence-based:

Clinical Trial Results:

FDA approval based on the LIGHTSITE III clinical trial
Study showed patients experienced measurable vision improvements
Drusen (protein deposits) were reduced in treated eyes
Safety profile: Well-tolerated with minimal adverse events

Who It’s For:

Patients with dry age-related macular degeneration (AMD)
Early to intermediate stages of dry AMD
Those seeking an alternative to injections or supplements alone

Who Should Consult First:

Patients with advanced geographic atrophy (your doctor will assess)
Those with other retinal conditions (individual evaluation needed)
Anyone unsure if they’re a candidate

Important Note:

Individual results vary. Some patients see improvement within weeks; others may take longer. Your retina specialist will monitor your progress and adjust your treatment plan as needed.

Your Questions Answered

>Yes. Valeda Light Therapy received FDA approval in November 2024 for treating dry age-related macular degeneration. Clinical studies have shown it to be safe, effective, and well-tolerated.

Most patients begin with 9 sessions over 4–6 weeks. Some notice improvements within a few weeks, while others progress more gradually. Many benefit from maintenance sessions later in the year. Your doctor will create a plan based on your specific needs.

Yes. Each session treats both eyes and takes about 20 minutes.

Valeda is non-invasive and typically very comfortable. Some patients experience mild, temporary eye sensitivity after treatment, but most report no significant side effects.

Coverage varies. Most insurance plans do not currently cover Valeda, but this is evolving. Our team can help you check your benefits and provide documentation if your insurer allows appeals.

Not exactly. Valeda helps improve visual function and slow progression, but it is not a cure. It works best as part of a comprehensive AMD care plan that may include supplements, lifestyle adjustments, and regular monitoring.

Unlike supplements or wet AMD injections, Valeda uses photobiomodulation to stimulate retinal cells. It is gentle, non-invasive, and designed to improve visual performance, not just slow decline.